Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Calgary

$25,000.00

Development of Microneedle-Based High Density Electromyography Arrays for Improved Diagnostics and Monitoring of Neurological Disorders

EF 2024-25

Résumé
When working with patients in rehabilitation and therapy settings, time and comfort are essential. Microneedles have already been identified as good medical and economical advances for patient wellbeing. Microneedles are small, sub-millimeter, projections that allow for pain free interactions with dermal tissues. Typically these are used for advanced drug delivery applications in which drug compounds can be painlessly delivered with similar efficacy to traditional hypodermic injections. More recently, there are efforts towards the development of biosensors using solid metal microneedles for enhanced biomonitoring and point of care therapies. As microneedles bypass the electrically insulative stratum corneum layer of the skin, biosignal acquisition is greatly enhanced over traditional planar electrodes used for surface measurements in electromyography (EMG). In order to perform accurate biosensing, solid microneedles must either be fabricated directly from conductive materials or post-processed to become conductive. Titanium and stainless steel are the most common materials used to date; however, their poor electrical conductivity makes them unsuitable for accurate biosignal sensing. This work focuses on the use of microneedles as enhanced dry electrodes for surface biopotential measurements for EMG applications. Utilizing the advanced solid metal microneedle manufacturing techniques developed by the Dalton lab in collaboration with the medical device expertise of the O'Cearbhaill lab and research experience in EMG of the Lowery lab, this grant will develop a novel flexible high density EMG electrode array. The development of microneedles into a flexible patch allows for simple application by both medical practitioner and user. The technology investigated by this grant will improve not only signal acquisition, but patient comfort, quality of life, and quality of care, reducing the burden of diagnosis and monitoring of neurological disorders.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
597593-2024
Name nom
Dalton, Colin C
Department département
Electrical and Software Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2518
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Instrumentation and measurements
Research subject fr
Instrumentation et mesures
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Development of Microneedle-Based High Density Electromyography Arrays for Improved Diagnostics and Monitoring of Neurological Disorders
Keywords
biomedical engineering; biopotentials; biosignals; electromyography; microfabrication; microneedles; neurological disorders; signal analysis
Application summary
When working with patients in rehabilitation and therapy settings, time and comfort are essential. Microneedles have already been identified as good medical and economical advances for patient wellbeing. Microneedles are small, sub-millimeter, projections that allow for pain free interactions with dermal tissues. Typically these are used for advanced drug delivery applications in which drug compounds can be painlessly delivered with similar efficacy to traditional hypodermic injections. More recently, there are efforts towards the development of biosensors using solid metal microneedles for enhanced biomonitoring and point of care therapies. As microneedles bypass the electrically insulative stratum corneum layer of the skin, biosignal acquisition is greatly enhanced over traditional planar electrodes used for surface measurements in electromyography (EMG). In order to perform accurate biosensing, solid microneedles must either be fabricated directly from conductive materials or post-processed to become conductive. Titanium and stainless steel are the most common materials used to date; however, their poor electrical conductivity makes them unsuitable for accurate biosignal sensing. This work focuses on the use of microneedles as enhanced dry electrodes for surface biopotential measurements for EMG applications. Utilizing the advanced solid metal microneedle manufacturing techniques developed by the Dalton lab in collaboration with the medical device expertise of the O'Cearbhaill lab and research experience in EMG of the Lowery lab, this grant will develop a novel flexible high density EMG electrode array. The development of microneedles into a flexible patch allows for simple application by both medical practitioner and user. The technology investigated by this grant will improve not only signal acquisition, but patient comfort, quality of life, and quality of care, reducing the burden of diagnosis and monitoring of neurological disorders.